S&P 500   3,014.73 (-3.26%)
DOW   26,065.97 (-3.31%)
QQQ   208.53 (-3.67%)
AAPL   277.17 (-5.29%)
FB   191.71 (-2.78%)
MSFT   163.18 (-4.11%)
GOOGL   1,350.23 (-2.89%)
AMZN   1,906.02 (-3.72%)
CGC   17.87 (-9.84%)
NVDA   250.27 (-6.49%)
BABA   203.21 (-2.65%)
MU   50.11 (-4.32%)
GE   10.43 (-4.75%)
TSLA   681.11 (-12.54%)
AMD   42.93 (-9.62%)
T   35.88 (-3.29%)
ACB   1.36 (-9.95%)
F   6.96 (-3.47%)
NFLX   384.83 (+1.47%)
BAC   29.21 (-4.67%)
DIS   119.07 (-3.48%)
GILD   74.77 (+0.09%)
S&P 500   3,014.73 (-3.26%)
DOW   26,065.97 (-3.31%)
QQQ   208.53 (-3.67%)
AAPL   277.17 (-5.29%)
FB   191.71 (-2.78%)
MSFT   163.18 (-4.11%)
GOOGL   1,350.23 (-2.89%)
AMZN   1,906.02 (-3.72%)
CGC   17.87 (-9.84%)
NVDA   250.27 (-6.49%)
BABA   203.21 (-2.65%)
MU   50.11 (-4.32%)
GE   10.43 (-4.75%)
TSLA   681.11 (-12.54%)
AMD   42.93 (-9.62%)
T   35.88 (-3.29%)
ACB   1.36 (-9.95%)
F   6.96 (-3.47%)
NFLX   384.83 (+1.47%)
BAC   29.21 (-4.67%)
DIS   119.07 (-3.48%)
GILD   74.77 (+0.09%)
S&P 500   3,014.73 (-3.26%)
DOW   26,065.97 (-3.31%)
QQQ   208.53 (-3.67%)
AAPL   277.17 (-5.29%)
FB   191.71 (-2.78%)
MSFT   163.18 (-4.11%)
GOOGL   1,350.23 (-2.89%)
AMZN   1,906.02 (-3.72%)
CGC   17.87 (-9.84%)
NVDA   250.27 (-6.49%)
BABA   203.21 (-2.65%)
MU   50.11 (-4.32%)
GE   10.43 (-4.75%)
TSLA   681.11 (-12.54%)
AMD   42.93 (-9.62%)
T   35.88 (-3.29%)
ACB   1.36 (-9.95%)
F   6.96 (-3.47%)
NFLX   384.83 (+1.47%)
BAC   29.21 (-4.67%)
DIS   119.07 (-3.48%)
GILD   74.77 (+0.09%)
S&P 500   3,014.73 (-3.26%)
DOW   26,065.97 (-3.31%)
QQQ   208.53 (-3.67%)
AAPL   277.17 (-5.29%)
FB   191.71 (-2.78%)
MSFT   163.18 (-4.11%)
GOOGL   1,350.23 (-2.89%)
AMZN   1,906.02 (-3.72%)
CGC   17.87 (-9.84%)
NVDA   250.27 (-6.49%)
BABA   203.21 (-2.65%)
MU   50.11 (-4.32%)
GE   10.43 (-4.75%)
TSLA   681.11 (-12.54%)
AMD   42.93 (-9.62%)
T   35.88 (-3.29%)
ACB   1.36 (-9.95%)
F   6.96 (-3.47%)
NFLX   384.83 (+1.47%)
BAC   29.21 (-4.67%)
DIS   119.07 (-3.48%)
GILD   74.77 (+0.09%)
Log in

NYSEAMERICAN:CRHM - CRH Medical Stock Price, Forecast & News

$3.42
-0.20 (-5.52 %)
(As of 02/27/2020 10:32 AM ET)
Today's Range
$3.42
Now: $3.42
$3.51
50-Day Range N/A
52-Week Range
$2.51
Now: $3.42
$4.43
Volume589 shs
Average Volume68,016 shs
Market Capitalization$244.90 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. Read More…

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:CRHM
Previous SymbolNYSEARCA:CRHM
CUSIPN/A
CIKN/A
Phone+1-604-6331440

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees112
Market Cap$244.90 million
Next Earnings Date3/11/2020 (Estimated)
OptionableNot Optionable

Receive CRHM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRHM and its competitors with MarketBeat's FREE daily newsletter.


CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions

What is CRH Medical's stock symbol?

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

How were CRH Medical's earnings last quarter?

CRH Medical Corp (NYSEAMERICAN:CRHM) issued its earnings results on Wednesday, August, 1st. The company reported $0.02 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.01 by $0.01. The business had revenue of $27.33 million for the quarter, compared to the consensus estimate of $25.70 million. View CRH Medical's Earnings History.

When is CRH Medical's next earnings date?

CRH Medical is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for CRH Medical.

What is the consensus analysts' recommendation for CRH Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CRH Medical.

Has CRH Medical been receiving favorable news coverage?

Media coverage about CRHM stock has trended negative on Thursday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CRH Medical earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for CRH Medical.

Are investors shorting CRH Medical?

CRH Medical saw a drop in short interest in February. As of February 14th, there was short interest totalling 3,600 shares, a drop of 72.5% from the January 30th total of 13,100 shares. Based on an average daily trading volume, of 57,700 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company's stock are short sold. View CRH Medical's Current Options Chain.

Who are some of CRH Medical's key competitors?

What other stocks do shareholders of CRH Medical own?

Who are CRH Medical's key executives?

CRH Medical's management team includes the folowing people:
  • Mr. Edward Wright, CEO & Non-Independent Director (Age 56)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 56)
  • Mr. James Kreger, Pres of CRH Anesthesia Management
  • Ms. Kettina Cordero, Director of Investor Relations

Who are CRH Medical's major shareholders?

CRH Medical's stock is owned by many different of retail and institutional investors. Top institutional investors include Stadium Capital Management LLC (6.80%), Beutel Goodman & Co Ltd. (6.10%), Pacific Ridge Capital Partners LLC (3.55%), Stifel Financial Corp (3.07%), Connor Clark & Lunn Investment Management Ltd. (3.00%) and Goldman Sachs Group Inc. (2.14%). View Institutional Ownership Trends for CRH Medical.

Which major investors are selling CRH Medical stock?

CRHM stock was sold by a variety of institutional investors in the last quarter, including Beutel Goodman & Co Ltd., Stadium Capital Management LLC, Seizert Capital Partners LLC, Stifel Financial Corp and Wedge Capital Management L L P NC. View Insider Buying and Selling for CRH Medical.

Which major investors are buying CRH Medical stock?

CRHM stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Palladium Partners LLC, Pacific Ridge Capital Partners LLC, Acadian Asset Management LLC, Cumberland Partners Ltd, Goldman Sachs Group Inc., Connor Clark & Lunn Investment Management Ltd. and Spark Investment Management LLC. View Insider Buying and Selling for CRH Medical.

How do I buy shares of CRH Medical?

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRHM stock can currently be purchased for approximately $3.42.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of $244.90 million. CRH Medical employs 112 workers across the globe.View Additional Information About CRH Medical.

What is CRH Medical's official website?

The official website for CRH Medical is http://investors.crhsystem.com/.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


MarketBeat Community Rating for CRH Medical (NYSEAMERICAN CRHM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  190 (Vote Outperform)
Underperform Votes:  184 (Vote Underperform)
Total Votes:  374
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRHM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRHM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel